104 related articles for article (PubMed ID: 28937723)
1. NRG GI002: Moving the needle toward TNT in locally advanced rectal cancer.
George TJ; Wu C; You YN
Bull Am Coll Surg; 2016 Oct; 101(10):61-2. PubMed ID: 28937723
[No Abstract] [Full Text] [Related]
2. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
[TBL] [Abstract][Full Text] [Related]
3. In favor of total neoadjuvant therapy (TNT) for locally advanced rectal carcinoma.
Arias F; Asín G; Flamarique S; Hernández I; Suarez J
Clin Transl Oncol; 2020 May; 22(5):793-794. PubMed ID: 31309436
[No Abstract] [Full Text] [Related]
4. Total neoadjuvant therapy for rectal cancer.
Goodman KA
Cancer Radiother; 2018 Sep; 22(5):459-465. PubMed ID: 29807808
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?
Hong TS; Ryan DP
J Clin Oncol; 2015 Jun; 33(17):1878-80. PubMed ID: 25940719
[No Abstract] [Full Text] [Related]
6. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
7. [Treatment for locally-advanced rectal cancer].
Berdov BA; Nevol'skikh AA; Erygin DV; Timova LN
Vopr Onkol; 2007; 53(5):578-83. PubMed ID: 18154125
[No Abstract] [Full Text] [Related]
8. [Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin in rectal cancer: initial results of the CAO/ARO/AIO-04 study].
Reibetanz J; Germer CT
Chirurg; 2012 Nov; 83(11):995. PubMed ID: 23089949
[No Abstract] [Full Text] [Related]
9. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.
Kripp M; Wieneke J; Kienle P; Welzel G; Brade J; Horisberger K; Wenz F; Post S; Gencer D; Hofmann WK; Hofheinz RD
Eur J Surg Oncol; 2012 Jun; 38(6):472-7. PubMed ID: 22349986
[TBL] [Abstract][Full Text] [Related]
10. Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging.
Ihn MH; Kim YH; Kim DW; Oh HK; Lee SY; Park JT; Son IT; Park JH; Lee YJ; Kim JW; Lee KW; Kim JH; Shin E; Lee HS; Ahn S; Kang SB
Ann Surg Oncol; 2015 Jul; 22(7):2159-67. PubMed ID: 25503346
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
12. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
13. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.
Berardi R; Maccaroni E; Onofri A; Giampieri R; Bittoni A; Pistelli M; Scartozzi M; Pierantoni C; Bianconi M; Cascinu S
Expert Opin Pharmacother; 2009 Oct; 10(14):2245-58. PubMed ID: 19640208
[TBL] [Abstract][Full Text] [Related]
15. The short-term outcomes of induction SOX (S-1 + oxaliplatin) ± cetuximab chemotherapy followed by short-course chemoradiotherapy in patients with poor-risk locally advanced rectal cancer.
Beppu N; Yoshie H; Kimura F; Aihara T; Doi H; Kamikonya N; Matsubara N; Tomita N; Yanagi H; Yamanaka N
Surg Today; 2016 Oct; 46(10):1123-31. PubMed ID: 26704191
[TBL] [Abstract][Full Text] [Related]
16. What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?
Glimelius B
Acta Oncol; 2016 Dec; 55(12):1381-1385. PubMed ID: 27879164
[No Abstract] [Full Text] [Related]
17. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
[TBL] [Abstract][Full Text] [Related]
18. Locally advanced rectal cancer: the importance of a multidisciplinary approach.
Berardi R; Maccaroni E; Onofri A; Morgese F; Torniai M; Tiberi M; Ferrini C; Cascinu S
World J Gastroenterol; 2014 Dec; 20(46):17279-87. PubMed ID: 25516638
[TBL] [Abstract][Full Text] [Related]
19. Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival Outcomes.
Jamnagerwalla M; Tay R; Steel M; Keck J; Jones I; Faragher I; Gibbs P; Wong R
Dis Colon Rectum; 2016 Oct; 59(10):916-24. PubMed ID: 27602922
[TBL] [Abstract][Full Text] [Related]
20. Pathological complete response: still a relevant endpoint in rectal cancer?
Chua YJ
Lancet Oncol; 2010 Sep; 11(9):807-8. PubMed ID: 20692871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
